Align Technology Profit Margin 2006-2019 | ALGN

Current and historical gross margin, operating margin and net profit margin for Align Technology (ALGN) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Align Technology net profit margin as of June 30, 2019 is 19.06%.
Align Technology Annual Profit Margins
Align Technology Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $17.086B $1.966B
Align Technology, Inc. is a global medical device company with industry-leading innovative products such as Invisalign clear aligners, iTero Intraoral scanners, and OrthoCAD digital services that help dental professionals achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $69.324B 22.73
McKesson (MCK) United States $27.830B 10.75
AmerisourceBergen (ABC) United States $18.811B 12.93
Laboratory Of America Holdings (LH) United States $16.658B 15.77
Cardinal Health (CAH) United States $14.974B 9.70
Cooper (COO) United States $14.488B 24.52
Straumann Holding AG (SAUHF) Switzerland $13.854B 0.00
DENTSPLY SIRONA (XRAY) United States $12.319B 26.04
West Pharmaceutical Services (WST) United States $10.444B 45.39
Henry Schein (HSIC) United States $9.422B 16.77
CONMED (CNMD) United States $2.749B 41.89
Merit Medical Systems (MMSI) United States $1.672B 17.42
Patterson (PDCO) United States $1.670B 12.40
Atrion (ATRI) United States $1.484B 41.28
STAAR Surgical (STAA) United States $1.228B 72.58
Antares Pharma (ATRS) United States $0.564B 0.00
Invacare (IVC) United States $0.225B 0.00
Lifevantage (LFVN) United States $0.203B 24.39
Endologix (ELGX) United States $0.064B 0.00
Milestone Scientific (MLSS) United States $0.057B 0.00
Pro-Dex (PDEX) United States $0.055B 17.52
Retractable Technologies (RVP) United States $0.036B 0.00
Biolase (BIOL) United States $0.022B 0.00